Published 2010 | Version v1
Journal article

Malignant transformation to schwannoma in a patient affected by type 1 neurofibromatosis as demonstrated by F-18-FDG-PET/CT

  • 1. Nuclear Medicine Department, Spedali Civili Brescia, Brescia (Italy)
  • 2. Biomedical Technology Department, University of Brescia, Brescia (Italy)
  • 3. Chair of Pathological Anatomy, University of Brescia, Brescia (Italy)
  • 4. 1st Division of Pathological Anatomy, University of Brescia, Brescia (Italy)
  • 5. Chair of Nuclear Medicine, University of Brescia, Brescia (Italy)

Description

Neurofibromatosis type I (NF1) is an autosomal dominant multisystem disorder. Patients with NF1 are at increased risk for developing both benign and malignant tumours. We report the case of a patient with histologically documented NF1, who underwent F18-FDG-PET/CT for staging purposes. The study revealed intense uptake at multiple masses located at the thighs (the largest presented SUV max of 6.8), popliteal regions, legs, left foot, left supraclavicular region, and at the thoracic wall between the 11th and 12th right ribs. The surgical biopsy of the largest popliteal lesion with higher uptake at F18-FDG-PET/CT documented the presence of a malignant schwannoma at histological examination. In conclusion, F18-FDG-PET/CT was probably able to help the discrimination between benign lesions related to known NF1 and the malignant transformed ones, and to assist clinical decision making. (authors)

Additional details

Identifiers

Publishing Information

Journal Title
Nuclear Medicine Review
Journal Volume
13
Journal Issue
1
Series
10 refs., 2 figs.
Journal Page Range
p. 15-17
ISSN
1506-9680